Evidence map›Paper›PMID 42807234›Full record

ArticleFrontiers in medicine2026

Case Report: Long-term visual rehabilitation in extreme early-onset axial myopia complicated by retinal detachment.

Yue Wu, Wensheng Li

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yue WuShanghai Aier Eye Hospital, Aier Eye Hospital Group Co., Ltd., Shanghai, China.
Wensheng LiShanghai Aier Eye Hospital, Aier Eye Hospital Group Co., Ltd., Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extreme early-onset axial myopia causes profound refractive disability and lifelong vitreoretinal vulnerability. We report approximately 20 years of follow-up in a woman with bilateral myopia of -8.00 diopters (D) at 1 year of age, axial lengths exceeding 30 mm at 6 years and 35 mm before adulthood. At 18 years, severe spectacle-related minification, peripheral distortion, and inconvenience persisted. After discussion of contact lenses, phakic intraocular lenses, and refractive lens exchange, she chose sequential bilateral refractive lens exchange with toric intraocular lenses and a residual myopic target of approximately -4.50 D. Eighteen days after right-eye surgery, she presented with a 3-day history of visual-field obscuration and was found to have a macula-off, multibreak rhegmatogenous retinal detachment. The eye underwent pars plana vitrectomy, endolaser photocoagulation, external cryotherapy, and silicone-oil tamponade; the oil was removed 5 months later. At the final visit, at 21 years of age, the axial lengths were 36.57 mm in the right eye and 36.17 mm in the left eye, and both retinas were attached. Visual acuity through the same-visit subjective refraction was logMAR 0.10 and 0.22 in the right and left eyes, respectively, whereas habitual spectacle-corrected visual acuity was logMAR 0.00 and 0.10. The patient reported improved daily visual function. This case shows that refractive lens exchange can reduce the optical burden of extreme myopic spectacles but does not remove the underlying vitreoretinal risk. It is a cautionary observation rather than a treatment recommendation and underscores individualized etiologic assessment, comparison of alternatives, conservative refractive targeting, peripheral retinal management, and lifelong surveillance.

Indexed as

case reportpathologic myopiarefractive lens exchangeretinal detachmentvisual rehabilitation

Identifiers

PMID42807234
PMCPMC13616698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.